Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo
Resistance to platinum agents is challenging in cancer treatment with platinum drugs. Such resistant cells prevent effective platinum accumulation intracellular and alter cellular adaptations to survive from cytotoxicity by regulating corresponding proteins expression. Ideal therapeutics should comb...
Saved in:
Main Authors: | Yu, Chang, Ding, Binbin, Zhang, Xinyang, Deng, Xiaoran, Deng, Kerong, Cheng, Ziyong, Xing, Bengang, Jin, Dayong, Ma, Ping'an, Lin, Jun |
---|---|
Other Authors: | School of Physical and Mathematical Sciences |
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/141679 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
MECHANISTIC INSIGHTS INTO PLATINUM (IV) PRODRUG COMPLEXES OF CISPLATIN FOR CANCER THERAPY
by: YAP SIEW QI
Published: (2017) -
INVESTIGATION OF ASYMMETRIC PLATINUM (IV) COMPLEXES AS ANTICANCER PRODRUGS
by: CHIN CHEE FEI
Published: (2015) -
Anticancer platinum (IV) prodrugs with novel modes of activity
by: Chin, C.F., et al.
Published: (2014) -
COMBINATION THERAPY THROUGH PLATINUM (IV) PRODRUG COMPLEXES INCORPORATING SELF-IMMOLATING LINKERS
by: LEE GUANG ZHI KEEFE
Published: (2018) -
Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin
by: Yoong, S.L., et al.
Published: (2014)